v3.26.3
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income
Balance beginning of period (in shares) at Dec. 31, 2024   77,450,794      
Balance beginning of period at Dec. 31, 2024 $ 1,760,005 $ 77 $ 5,730,367 $ (3,984,865) $ 14,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,792     6,792  
Unrealized gain (loss) on derivatives (1,586)       (1,586)
Reclassification to interest expense, net (2,242)       (2,242)
Distributions declared (18,438)     (18,438)  
Stock-based compensation, net (in shares)   116,970      
Stock-based compensation, net 275 $ 1 274    
Balance end of period (in shares) at Mar. 31, 2025   77,567,764      
Balance end of period at Mar. 31, 2025 1,744,806 $ 78 5,730,641 (3,996,511) 10,598
Balance beginning of period (in shares) at Dec. 31, 2024   77,450,794      
Balance beginning of period at Dec. 31, 2024 1,760,005 $ 77 5,730,367 (3,984,865) 14,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 108,760        
Unrealized gain (loss) on derivatives (2,637)        
Reclassification to interest expense, net (6,851)        
Balance end of period (in shares) at Sep. 30, 2025   77,619,380      
Balance end of period at Sep. 30, 2025 1,809,113 $ 78 5,735,537 (3,931,440) 4,938
Balance beginning of period (in shares) at Mar. 31, 2025   77,567,764      
Balance beginning of period at Mar. 31, 2025 1,744,806 $ 78 5,730,641 (3,996,511) 10,598
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 95,942     95,942  
Unrealized gain (loss) on derivatives (43)       (43)
Reclassification to interest expense, net (2,293)       (2,293)
Distributions declared (18,447)     (18,447)  
Stock-based compensation, net (in shares)   38,632      
Stock-based compensation, net 2,321   2,321    
Balance end of period (in shares) at Jun. 30, 2025   77,606,396      
Balance end of period at Jun. 30, 2025 1,822,286 $ 78 5,732,962 (3,919,016) 8,262
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,026     6,026  
Unrealized gain (loss) on derivatives (1,008)       (1,008)
Reclassification to interest expense, net (2,316)       (2,316)
Distributions declared (18,450)     (18,450)  
Stock-based compensation, net (in shares)   12,984      
Stock-based compensation, net 2,575   2,575    
Balance end of period (in shares) at Sep. 30, 2025   77,619,380      
Balance end of period at Sep. 30, 2025 $ 1,809,113 $ 78 5,735,537 (3,931,440) 4,938
Balance beginning of period (in shares) at Dec. 31, 2025 77,691,533 77,691,533      
Balance beginning of period at Dec. 31, 2025 $ 1,794,262 $ 78 5,736,652 (3,947,229) 4,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 5,184     5,184  
Unrealized gain (loss) on derivatives 2,838       2,838
Reclassification to interest expense, net (1,606)       (1,606)
Distributions declared (19,484)     (19,484)  
Stock-based compensation, net (in shares)   244,324      
Stock-based compensation, net (3,112)   (3,112)    
Balance end of period (in shares) at Mar. 31, 2026   77,935,857      
Balance end of period at Mar. 31, 2026 $ 1,778,082 $ 78 5,733,540 (3,961,529) 5,993
Balance beginning of period (in shares) at Dec. 31, 2025 77,691,533 77,691,533      
Balance beginning of period at Dec. 31, 2025 $ 1,794,262 $ 78 5,736,652 (3,947,229) 4,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 25,966        
Unrealized gain (loss) on derivatives 20,287        
Reclassification to interest expense, net $ (4,782)        
Balance end of period (in shares) at Sep. 30, 2026 77,978,431 77,978,431      
Balance end of period at Sep. 30, 2026 $ 1,779,500 $ 78 5,738,889 (3,979,733) 20,266
Balance beginning of period (in shares) at Mar. 31, 2026   77,935,857      
Balance beginning of period at Mar. 31, 2026 1,778,082 $ 78 5,733,540 (3,961,529) 5,993
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,369     1,369  
Unrealized gain (loss) on derivatives (1,483)       (1,483)
Reclassification to interest expense, net 4,818       4,818
Distributions declared (19,492)     (19,492)  
Stock-based compensation, net (in shares)   30,604      
Stock-based compensation, net 2,388   2,388    
Balance end of period (in shares) at Jun. 30, 2026   77,966,461      
Balance end of period at Jun. 30, 2026 1,765,682 $ 78 5,735,928 (3,979,652) 9,328
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 19,413     19,413  
Unrealized gain (loss) on derivatives 18,932       18,932
Reclassification to interest expense, net (7,994)       (7,994)
Distributions declared (19,494)     (19,494)  
Stock-based compensation, net (in shares)   11,970      
Stock-based compensation, net $ 2,961   2,961    
Balance end of period (in shares) at Sep. 30, 2026 77,978,431 77,978,431      
Balance end of period at Sep. 30, 2026 $ 1,779,500 $ 78 $ 5,738,889 $ (3,979,733) $ 20,266